BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ciprofibrate
,
rs7903146
,
FXYD4
,
T cell differentiation
,
Allergy to pollen
,
Leukocyte
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mao- inhibitors
Summary
General Info
Curated Studies
Most Correlated Studies
Jurkat cells, NK-92 cells, and THP-1 cells treated with methamphetamine
Hepatic stellate cell myofibroblasts treated with TGFB1, nortriptyline or ceramide
Leukemia MV4-11 cells treated with ASH1L histone methyltransferase inhibitor AS-99
Primary-like dendritic cells with BCL2 knockout or treated with BCL2 inhibitor venetoclax
Neurons differentiated from iPSCs of frontotemporal dementia patients with or without GRN mutations
Explore Curated Studies Results
Literature
Most Relevant Literature
An updated patent review on monoamine oxidase (MAO) inhibitors.
The potential of MAO inhibitors as chemotherapeutics in cancer: A literature survey.
A second life for MAO inhibitors? From CNS diseases to anticancer therapy.
A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke.
The use of MAOIs in primary care.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Thera…
A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO…
Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD an…
Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhib…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ